News
Scarlett Johansson directed her first film, Eleanor the Great. The movie premiered at the Cannes Film Festival in 2025. June ...
Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...
Bristol Myers Squibb and BioNTech to co-develop cancer immunotherapy BNT327 in a deal worth up to $11.1 billion.
PRINCETON, NJ / ACCESS Newswire / June 6, 2025 / Originally published on University of Kentucky Research NewsA groundbreaking lung cancer screening project co-led by the University of Kentucky Markey ...
4don MSN
Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...
BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones ...
Bloomberg reported that Bristol-Myers Squibb Company (NYSE:BMY) and BioNTech SE (NASDAQ:BNTX) announced a strategic licensing ...
This decision came after the company entered into an agreement with Bristol Myers Squibb for the co-development and ...
Dr. Radhakrishnan brings significant experience in product development and commercialization that will be particularly ...
Under terms of the deal, both companies will co-develop and co-commercialize BNT327 for multiple solid tumors, with the ...
18h
News-Medical.Net on MSNMitochondrial DNA variant predicts resistance to melanoma immunotherapyResults from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results